MDMA-Assisted Therapy: FDA Update
An update on the FDA status of MDMA-assisted therapy and what to expect going forward. The page indicates a 3-month duration, but provides no further course details.
Course Overview
This course page is titled "MDMA-Assisted Therapy: FDA Update" and appears to focus on the FDA status of MDMA-assisted therapy and expected next steps. The available source text does not provide a syllabus, session breakdown, or instructor information. Based on the page excerpt, the course may be intended for readers following current developments in psychedelic-assisted therapy. No prerequisites, assessment details, certification information, or credit information are stated in the source excerpt. The only structured detail available from the page is a duration of 3 months. Other fields are left null where the source does not clearly support them.
Who is this for?
People following updates on MDMA-assisted therapy and the FDA review process.
Course Details
- PriceFree
- Lifecycle statusNo New Dates
- SkillsIntegrationPsychotherapyKetamine-Assisted TherapyMDMA-Assisted TherapyEthicsTrauma-Informed Care
- Categories
You will be redirected to the provider's website
Related Courses
View all coursesCertificate in Psychedelic-Assisted Therapies & Research | CIISCIIS LogoCIIS Logo
A 12-month certificate in psychedelic-assisted therapies and research offered by CIIS. The program includes hybrid or online study and covers clinical competencies, research, cultural context, and ethical practice.
FDA On MDMA-Assisted Psychotherapy
This page discusses the FDA's rejection of MDMA-assisted psychotherapy and summarizes the rationale given for further research. It also reviews MDMA's history, reported therapeutic uses, and MAPS' response to the decision.
Automated status check: No valid upcoming cohort date found on the source page (checked 2026-04-12).
MAPS International MDMA-assisted Therapy Training Program
A collaboration between MAPS and the Clinical Psychedelic Lab at Monash University, this training program prepares mental healthcare professionals to support MDMA-assisted psychotherapy for PTSD. It combines online learning with a week-long in-person residential intensive and is limited to 65 trainees.
Automated status check: No valid upcoming cohort date found on the source page (checked 2026-04-12).